胰腺癌是一种发病率持续攀升的侵袭性全身性疾病，预计到2030年将成为癌症相关死亡的第二大常见原因。胰腺癌的预后普遍较差，相关诊疗指南中标准诊疗路径和标准治疗方案的更新一直为广大临床医生所关注。近期，美国国家综合癌症网络（NCCN）更新了胰腺癌2025 ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

The new NCCN Guidelines for Patients ®: Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer is ...

During the international meeting, experts from across the region will present new and updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®): MENA Editions, and selected topics ...

Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the inclusion of circulating tumor DNA (ctDNA) testing in the National ...

"The inclusion of ctDNA testing in the NCCN Guidelines brings Foresight closer to our mission of improving the lives of cancer patients worldwide by delivering innovative diagnostics that provide ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed treatment for a patient with chronic ...

Daly, MD, PhD, FACP, Fox Chase Cancer Center; and Chair of the NCCN Guidelines ® Panel for Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate. “The changes have ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions ...

During the international meeting, experts from across the region will present new and updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): MENA Editions, and selected topics ...

Christina Henson, MD, discussed some of the current imaging guidelines in head and neck cancer, with a focus on extranodal ...